Breaking News Instant updates and real-time market news.

IRTC

iRhythm

$55.50

-0.33 (-0.59%)

09:30
12/01/17
12/01
09:30
12/01/17
09:30

iRhythm initiated with a Neutral at Dougherty

IRTC iRhythm
$55.50

-0.33 (-0.59%)

09/22/17
ADAM
09/22/17
NO CHANGE
Target $55
ADAM
Buy
Canaccord says to add to iRhythm positions, raises price target to $55
Canaccord analyst Jason Mills recommends investors add to iRhythm's positions and raised his price target to $55 from $49. The analyst said iRhythm has a "huge" competitive moat with a business model that can generate "elite" EBITDA margins. Mills said iRhythm has built and continues to advance its Zio platform that will ultimately change the standard in ambulatory ECG monitoring. The analyst rates shares a Buy.
09/15/17
BNCH
09/15/17
NO CHANGE
Target $44
BNCH
Buy
Benchmark says BioTelemetry has big head start over iRhythm
Following Off Wall Street's Sell rating on BioTelemetry, Benchmark analyst Bill Sutherland says recent discussions with management has raised no "red flags" about the outlook for the company's legacy business. In an email to investors, the analyst notes that BioTelemetry has a large head start over competitor iRhythm (IRTC), which Off Wall Street references in its short report. He adds that the holter monitor segment, while large, is not BioTelemetry's focus. Sutherland has a Buy rating on the shares with a $44 price target. BioTelemetry is down 11%, or $4.15, to $32.95 in afternoon trading.
07/17/17
ADAM
07/17/17
NO CHANGE
ADAM
M&A in med-tech space will accelerate, says Canaccord
Canaccord analyst Jason Mills remains cautious in the med-tech space but believes M&A will continue to be a major theme. He noted the sector is trading at peak levels and recommends trading around core positions and looking for pullbacks to average down in favorite names. He said the most likely takeout names, in this order, are, Nevro (NVRO), AtriCure (ATRC), NxStage Medical (NXTM), iRhythm (IRTC), and Penumbra (PEN).
06/05/17
MSCO
06/05/17
NO CHANGE
Target $47
MSCO
Overweight
iRhythm price target raised to $47 from $43 at Morgan Stanley
Morgan Stanley analyst David Lewis raised iRhythm's price target to $47 from $43 saying recent management meetings increase his confidence in execution and said the growth picture for 2018-2021 remains robust and he sees new product and clinical catalysts supporting ZIO growth. The analyst believes core atrial fibrillation penetration, market expansion, and margin upside support above consensus estimates and reiterates his Overweight rating.

TODAY'S FREE FLY STORIES

GLYC

GlycoMimetics

$14.32

-0.65 (-4.34%)

08:57
12/12/17
12/12
08:57
12/12/17
08:57
Recommendations
GlycoMimetics analyst commentary  »

GlycoMimetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

08:56
12/12/17
12/12
08:56
12/12/17
08:56
General news
Redbook Store Sales data reported »

Week of 12/9 Redbook…

BAC

Bank of America

$28.94

-0.11 (-0.38%)

, T

AT&T

$36.90

0.17 (0.46%)

08:55
12/12/17
12/12
08:55
12/12/17
08:55
Options
Notable open interest changes for December 12th »

Monday's total…

BAC

Bank of America

$28.94

-0.11 (-0.38%)

T

AT&T

$36.90

0.17 (0.46%)

AAPL

Apple

$172.67

3.3 (1.95%)

MU

Micron

$43.01

-0.2 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 09

    Jan

08:55
12/12/17
12/12
08:55
12/12/17
08:55
General news
Treasury Action: yields extended their rise »

Treasury Action: yields…

HI

Hillenbrand

$45.10

-0.45 (-0.99%)

08:55
12/12/17
12/12
08:55
12/12/17
08:55
Conference/Events
Hillenbrand to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ARGX

Argenx

$54.47

24.02 (78.88%)

08:54
12/12/17
12/12
08:54
12/12/17
08:54
Technical Analysis
Technical View: Argenx falls after filing to sell $150M in ADSs »

In premarket trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$32.27

-0.82 (-2.48%)

08:53
12/12/17
12/12
08:53
12/12/17
08:53
Recommendations
Urban Outfitters analyst commentary  »

Urban Outfitters price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

H

Hyatt

$71.90

-0.39 (-0.54%)

08:53
12/12/17
12/12
08:53
12/12/17
08:53
Syndicate
Hyatt 2.7M share Block Trade priced at $71.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 12

    Dec

AGN

Allergan

$172.76

4.96 (2.96%)

08:53
12/12/17
12/12
08:53
12/12/17
08:53
Hot Stocks
Allergan receives FDA clearance for CoolSculpting treatment »

Allergan announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

GRMN

Garmin

$61.96

-0.31 (-0.50%)

08:52
12/12/17
12/12
08:52
12/12/17
08:52
Recommendations
Garmin analyst commentary  »

Garmin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
12/12/17
12/12
08:50
12/12/17
08:50
General news
FX Action: The dollar »

FX Action: The dollar…

ESL

Esterline

$70.80

0.95 (1.36%)

08:49
12/12/17
12/12
08:49
12/12/17
08:49
Recommendations
Esterline analyst commentary  »

Esterline price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$283.16

-2.74 (-0.96%)

08:48
12/12/17
12/12
08:48
12/12/17
08:48
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYCEY

Rolls-Royce

$11.08

-0.145 (-1.29%)

08:46
12/12/17
12/12
08:46
12/12/17
08:46
Hot Stocks
Rolls-Royce launches R2 Data Labs to accelerate data innovation »

Rolls-Royce has launched…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAOI

Applied Optoelectronics

$40.52

1.83 (4.73%)

, ROKU

Roku

$47.98

3.19 (7.12%)

08:45
12/12/17
12/12
08:45
12/12/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

AAOI

Applied Optoelectronics

$40.52

1.83 (4.73%)

ROKU

Roku

$47.98

3.19 (7.12%)

RSX

Market Vectors Russia ETF

$22.01

0.44 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIBB

Hibbett Sports

$20.20

0.05 (0.25%)

08:43
12/12/17
12/12
08:43
12/12/17
08:43
Technical Analysis
Technical View: Hibbett Sports moves higher on light volume »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$112.37

-0.23 (-0.20%)

08:42
12/12/17
12/12
08:42
12/12/17
08:42
Periodicals
Visa innovation chief had history of employee affairs before firing, Recode says »

Former Visa executive Jim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ATRO

Astronics

$42.06

-1.19 (-2.75%)

08:40
12/12/17
12/12
08:40
12/12/17
08:40
Recommendations
Astronics analyst commentary  »

Astronics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:40
12/12/17
12/12
08:40
12/12/17
08:40
General news
U.S. headline PPI rose 0.4% in November with the core rate up 0.3% »

U.S. headline PPI rose…

08:40
12/12/17
12/12
08:40
12/12/17
08:40
General news
Breaking General news story  »

Week of 12/9 Redbook to…

PEGI

Pattern Energy

08:38
12/12/17
12/12
08:38
12/12/17
08:38
Downgrade
Pattern Energy rating change  »

Pattern Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTLA

Portola Pharmaceuticals

$51.78

-1.24 (-2.34%)

08:38
12/12/17
12/12
08:38
12/12/17
08:38
Hot Stocks
Portola Pharmaceuticals: CHMP requests additional information for betrixaban MAA »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

08:38
12/12/17
12/12
08:38
12/12/17
08:38
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

SINA

Sina

$99.59

2.57 (2.65%)

, WB

Weibo

$104.00

3.76 (3.75%)

08:37
12/12/17
12/12
08:37
12/12/17
08:37
Periodicals
Sina to sell gaming subsidiary stake to Whole Easy, Mijiao, Marbridge Daily says »

Whole Easy Internet…

SINA

Sina

$99.59

2.57 (2.65%)

WB

Weibo

$104.00

3.76 (3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIK

Tel-Instrument

$2.30

-0.05 (-2.13%)

08:35
12/12/17
12/12
08:35
12/12/17
08:35
Hot Stocks
Tel-Instrument announces over $1M in new orders »

Tel-Instrument…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.